Surgical Robotics Technology
surgical robotics

PROCEPT BioRobotics Strengthens Board of Directors

procept-biorobotics

PROCEPT® BioRobotics, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, has announced the appointment of Elisabeth Sandoval to its Board of Directors.

Ms. Sandoval currently serves as a consultant to the pharmaceutical industry and is a member of the board of directors of Intersect ENT, Inc., Satsuma Pharmaceuticals, Inc. and Vyne Therapeutics, Inc. She is also on the Board of privately held Alastin Skincare. Ms. Sandoval previously served as the Chief Commercial Officer and Executive Vice President of Corporate Strategy at Alder Biopharmaceuticals. She was Chief Commercial Officer for Kythera Biopharmaceuticals and spent over 20 years at Allergan in a variety of commercial leadership roles of increasing responsibility.

“Ms. Sandoval is an accomplished healthcare executive. Her experience aligns with our current commercial strategies we are undertaking to accelerate the adoption of Aquablation therapy to become the standard of care for BPH,” said Reza Zadno, Procept BioRobotics CEO. “Ms. Sandoval’s well-rounded commercial experience and success reflects our focus on adding expertise to the board that will help oversee our rapid growth trajectory.”

“I am pleased to join PROCEPT BioRobotics’ Board of Directors and be a part of a company dedicated to improving the lives of men suffering from lower urinary tract symptoms (LUTS) due to BPH. I strongly believe my experience can help the company achieve their long-term growth objectives,” said Ms. Sandoval.

With the appointment of Ms. Sandoval, the Board of Directors of PROCEPT BioRobotics Corporation increased the number of directors on the Board to nine members.

Source: PROCEPT BioRobotics.

Surgical Robotics Technology

Join thousands of Surgical Robotics Experts and get the latest updates straight to your inbox!